Not applicableStudy completedNCT00801437
What this trial is testing
Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
Who this might be right for
Glaucoma, Open-angle
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 457